An investigation of the usability of different adrenaline autoinjector devices

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN29175528

Enrollment

200

Registered

2012-03-14

Start date

2012-03-14

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food allergy Injury, Occupational Diseases, Poisoning Anaphylactic shock due to adverse food reaction

Interventions

Randomised controlled assessment - subjects will be randomly allocated to have 1 of 4 different types of training assessment, but will not receive any active intervention apart from the assessment. P

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Completion of primary and secondary outcome assessments in MAMA trial (http://www.controlled-trials.com/ISRCTN12504076/) 2. Willingness to participate in a further assessment

Exclusion criteria

Exclusion criteria: Previous training to use one of the alternative adrenaline autoinjector devices used in this study

Design outcomes

Primary

Measure	Time frame
Ability to effectively administer adrenaline using a trainer autoinjector device in a simulated anaphylaxis scenario, assessed by a trained observer.	—

Secondary

Measure	Time frame
Adverse events during simulated anaphylaxis scenario, assessed by a trained observer.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026